Parametric Portfolio Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History

Parametric Portfolio Associates’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.16M	Buy
2021 Q4	$385K	Buy
2021 Q3	$253K	Buy